BRUIN MCL-321, a Phase 3 OpenLabel, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated, BTK Inhibitor Naive Mantle Cell Lymphoma (Trial in Progress)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2022）
关键词
MCL, pirtobrutinib, BTKi, mantle cell lymphoma, clinical trial, phase III, trial-in-progress
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要